Across TCGA pan-cancer cohorts, RNU2-68P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU2-68P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU2-68P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU2-68P is over-expressed in tumor.

BRCA, ESCA, and STAD are the cancer types where RNU2-68P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU2-68P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.194	.023	4	view →
ESCA	All	II,III,IV	+1.005	.032	2	view →
STAD	All	All	+0.430	.026	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU2-68P RNA expression & survival · all RNU2-68P data types